{"entity":{"type":"insider","cik":"0001718020","url":"/insider/0001718020","json_url":"/insider/0001718020.json","name":"SANDERS MACHELLE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2020-03-05","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"SANDERS MACHELLE","source":"filing","n_filings":6,"first_seen":"2020-03-05","last_seen":"2026-08-05"}],"transactions":[{"id":6010057,"accession":"0001965040-26-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001965040-26-000111","line_url":"/filing/0001965040-26-000111#line-1","is_derivative":false,"issuer_cik":"0001718020","issuer_name":"Fortrea Holdings Inc.","issuer_ticker":"FTRE","issuer_name_source":null,"issuer_url":"/issuer/0001718020","owner_cik":"0001718020","owner_name":"SANDERS MACHELLE","owner_display_name":"SANDERS MACHELLE","owner_url":"/insider/0001718020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":18.01,"price_display":"18.01","price_state":"stated","total_value":174697.0,"total_display":"174,697.00","total_whole":"174,697","shares_owned_after":36399.0,"shares_owned_after_display":"36,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider"},{"id":5189230,"accession":"0000882796-25-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000882796-25-000017","line_url":"/filing/0000882796-25-000017#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001718020","owner_name":"SANDERS MACHELLE","owner_display_name":"SANDERS MACHELLE","owner_url":"/insider/0001718020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":7.14,"price_display":"7.14","price_state":"stated","total_value":68544.0,"total_display":"68,544.00","total_whole":"68,544","shares_owned_after":30642.0,"shares_owned_after_display":"30,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":3158144,"accession":"0001127602-24-018846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-018846","line_url":"/filing/0001127602-24-018846#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001718020","owner_name":"SANDERS MACHELLE","owner_display_name":"SANDERS MACHELLE","owner_url":"/insider/0001718020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4689.0,"shares_display":"4,689","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":28134.0,"total_display":"28,134.00","total_whole":"28,134","shares_owned_after":27742.0,"shares_owned_after_display":"27,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-17","scope":"insider"},{"id":8128163,"accession":"0001467154-23-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001467154-23-000073","line_url":"/filing/0001467154-23-000073#line-1","is_derivative":false,"issuer_cik":"0001467154","issuer_name":"Novan, Inc.","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0001467154","owner_cik":"0001718020","owner_name":"SANDERS MACHELLE","owner_display_name":"SANDERS MACHELLE","owner_url":"/insider/0001718020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11553.0,"shares_display":"11,553","price_per_share":0.4082,"price_display":"0.41","price_state":"stated","total_value":4715.9346,"total_display":"4,715.93","total_whole":"4,716","shares_owned_after":25248.0,"shares_owned_after_display":"25,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-27","scope":"insider"},{"id":8536420,"accession":"0001127602-23-018783","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-018783","line_url":"/filing/0001127602-23-018783#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001718020","owner_name":"SANDERS MACHELLE","owner_display_name":"SANDERS MACHELLE","owner_url":"/insider/0001718020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":7.98,"price_display":"7.98","price_state":"stated","total_value":31920.0,"total_display":"31,920.00","total_whole":"31,920","shares_owned_after":25611.0,"shares_owned_after_display":"25,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-15","scope":"insider"},{"id":2126954,"accession":"0001467154-20-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001467154-20-000028","line_url":"/filing/0001467154-20-000028#line-1","is_derivative":false,"issuer_cik":"0001467154","issuer_name":"Novan, Inc.","issuer_ticker":"NOVN","issuer_name_source":null,"issuer_url":"/issuer/0001467154","owner_cik":"0001718020","owner_name":"SANDERS MACHELLE","owner_display_name":"SANDERS MACHELLE","owner_url":"/insider/0001718020","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001965040","name":"Fortrea Holdings Inc.","url":"/issuer/0001965040","role":"Director","n_filings":1,"first_seen":"2026-08-05","last_seen":"2026-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Director","n_filings":3,"first_seen":"2023-06-15","last_seen":"2025-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001467154","name":"Novan, Inc.","url":"/issuer/0001467154","role":"Director","n_filings":2,"first_seen":"2020-03-05","last_seen":"2023-06-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001718020","retrieved_at":"2026-08-26T07:19:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}